chrisvoncsefalvay/vaers-outcomes huggingface dataset:
headache; body aches; fatigue; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), MYALGIA (body aches) and FATIGUE (fatigue) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced HEADACHE (headache), MYALGIA (body aches) and FATIGUE (fatigue). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, HEADACHE (headache), MYALGIA (body aches) and FATIGUE (fatigue) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were reported
About 18 hours after the vaccine, I had a low grade fever, swelling in my arm. I started to feel better. On Sunday morning, 07/31/2022 I woke up with drainage and a sore throat. By Monday I noticed wheezing so I started taking my inhaler. On Tuesday I got out my nebulizer. I took a series of about 2 back to back treatments for about 6 hours to try and break some of the wheezing in my chest. I did not have relief so I contacted my doctor. The nurse told me I may have an upper respiratory infection, but I have not had a fever. The doctor added doses of prednisone and antibiotics on 08/03/2022 and more breathing treatments. Today I feel a little more relief but I am still going to take the steroids. I am on the steroids for 7 days and the antibiotic, Ceftin, for 10 days. I have also been taking at home COVID-19 tests and they are all negative.
Started to develop rash on face and chest (red and pimple like with clear fluid) on Saturday. Awoke on Sunday with rash in underarm area, more severe on left deltoid of MMR given (was also given Td on right deltoid).
Expired vaccine was accidently administered. Vaccine was  expired at the time of vaccination. No reports of adverse events, will offer re-vaccination at the recommendation of Moderna
ON 9/12/21 PATIENT CAME IN TO GET THE FLU SHOT VACCINE AND RECEIVED THE MODERNA VACCINE INSTEAD.  PT WAS CALLED TO BE TOLD THAT HE RECEIVED THE COVID VACCINE INSTEAD OF THE FLU AND REPORTED NO SIDE EFFECTS AT THE TIME OF THE CALL ON 9/12/21.  PT WIFE WAS CONCERNED BECAUSE THEY RECEIVED THE JOHNSON AND JOHNSON VACCINE IN APRIL OF 2021.  PHARMACIST ON DUTY REPORTED THAT THEY SHOULD BE FINE BUT WOULD PUT A CALL IN TO THE CDC FOR MORE INFORMATION. PT WANTED TO RETURN FOR THE CORRECT VACCINE BEFORE 9/13/21 FOR A FOSTER PARENT APPLICATION.
Client received KINRIX on 4/9/15 that had expired on 11/23/14.
Systemic: Abdominal Pain-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Nausea-Medium
This relates only to Moderna booster received on 12/16/21. beginning on 12/19 /21 I began to have severe diarrhea, pain  and inflammation in all my joints, and low grade fever chills and sweats and profound fatigue. These symptoms occurred after the initial reaction to the booster immediately followingnits receipt on 12/16/2021. those symptoms resolved within 36 hours. The symptoms I experienced  have lasted for a month. A gastroenterologist saw me for the diarrhea and said that he had seen other patients with similar protracted side effects from the booster. He prescribed Questran  which has helped. The  joint symptoms are lasting but are improving , likewise the  fatigue. However I still feel worse than I did before. My Covid  PCR test done at the time of my visit to Dr. is negative.
Patient reports aching in the left upper arm since vaccination. He also reports left thigh aching/myalgias as well that is dull. No numbness/tingling. This has been ongoing since 06/2020
Headache Muscle Pain Sore throat Fatigue Phlegm  Tylenol 1000 mg 3 times daily
COVID-19; This spontaneous case was reported by a physician and describes the occurrence of COVID-19 (COVID-19) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Aug-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (COVID-19). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) from 17-May-2022 to 21-May-2022 for COVID-19 treatment, at an unspecified dose and frequency. At the time of the report, COVID-19 (COVID-19) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not reported. The patient was not taking other medications/products within 2 weeks of starting COVID-19 treatment. The patient had previously received a COVID-19 Vaccine. Patent had a rebound COVID on 26May2022. Device Date : 27-May-2022. Treatment medication was not reported.  Company comment-This spontaneous case concerns a 67-year-old male patient with no medical history reported, who experienced the unexpected non-serious AESI event of COVID-19 on an unknown date after receiving the third dose of mRNA-1273 vaccine. It was reported that patient was treated with Paxlovid for Covid-19 from 17th to 21st May2022. Patient had rebound covid-19 five days after completion of Paxlovid. The current pandemic situation of COVID-19 may remain as confounder to the event Covid-19.  The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.; Sender's Comments: This spontaneous case concerns a 67-year-old male patient with no medical history reported, who experienced the unexpected non-serious AESI event of COVID-19 on an unknown date after receiving the third dose of mRNA-1273 vaccine. It was reported that patient was treated with Paxlovid for Covid-19 from 17th to 21st May2022. Patient had rebound covid-19 five days after completion of Paxlovid. The current pandemic situation of COVID-19 may remain as confounder to the event Covid-19.  The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.
blood sugar went up; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE INCREASED (blood sugar went up) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012L201A, 016M201A and 040C21A) for COVID-19 vaccination.     The patient's past medical history included Laser therapy (18 eye laser treatments) and Keratectomy. Concurrent medical conditions included Type 1 diabetes mellitus, Cancer, COPD and Arthritis. Concomitant products included INSULIN for Blood sugar increased.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BLOOD GLUCOSE INCREASED (blood sugar went up). At the time of the report, BLOOD GLUCOSE INCREASED (blood sugar went up) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No treatment drugs were reported.  The patient had to take an extra dose that time and adjust the dose of the insulin for a few days before it got controlled.  On 15-Feb-2021,The patient received second dose and  03-Sep-2021, received third dose of Moderna vaccine.
Initial unsolicited report received from a non-healthcare professional on 23 November 2015. This case is linked with 2015SA194968 (same reporter). This case involves a male patient who was vaccinated with a dose of FLUZONE HD) (batch number, expiration date, dose, dose number, were not reported) on an unspecified date. The patient's medical history and concomitant medication were not reported. On unspecified date, following the vaccination, the patient experienced anaphylactic symptoms. Laboratory investigations and corrective treatments were not reported. The outcome of the event was not reported. Upon internal review, the case was considered to be serious due to important medical events: anaphylactic reaction List of documents held by sender: none.; Sender's Comments: This is poorly documented medically not confirmed case. In which the consumer reported as anaphylactic reaction occurred after administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE. However, investigation results ruling out a concurrent infection and other etiologies would be helpful to further assess this case. Based on the information the role of the vaccine cannot be assessed.
feeling "tired"; This is a spontaneous report from a non-contactable consumer (patient).  A female consumer of unknown age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 10Mar2021 at single dose for COVID-19 immunization. Medical history and concomitant medications were unknown. The patient felt very tired on unknown date. The outcome of the event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Patient was given a Hep A on 5-29-19 but the vaccine expired on 5-27-19. Patient had no adverse reaction. This dose will not count as part of patient's immunization schedule. Patient mother has been contacted and is aware that this dose is invalid due to being expired and that patient will need another dose in 6 months.
This case was received from a health professional in the United States on 08 May 2008, and is one of three patients reported in a cluster. A two-month-old male patient received an intramuscular right leg first injection of DAPTACEL (lot number C2950AA), an intramuscular right leg first injection of IPOL (lot not known), an intramuscular left leg first injection of ActHIB (lot number not known), an intramuscular left leg first injection of Prevnar (Wyeth, lot unknown), and an intramuscular right leg first injection of Hepatitis B (Merck, lot number unknown) on 07 May 2008. Four hours later, the patient was noted to have right leg swelling the size of an orange, as well as limb redness, warmth, and pain. Temperature was 100.9 degrees Fahrenheit, and the patient was sent to the emergency room for sepsis work-up. Per the reporter, the name of the emergency room and treating physician were not known. Treatment, diagnosis, and outcome were unknown. The reporter of this case also reported two other patients with large local limb swelling following administration of DAPTACEL; those events are captured in case numbers 2008-01480 and 2008-01481.
Vanish Point syringe malfunction first dose only administered 0.1 ml and 0.4 ml leaked out of syringe at Hub. Full dose of 0.5 ml administered in opposite . No adverse reactions noted.
Severe local swelling, headache, fatigue, fever,  sweating, chills, muscle aches and pain, head fogginess,
one of three pts who was vaxed from the same vial & exp fever, fussiness & severe local reaction; pt devel an abscess; Reporter states vial contains broken glass; no broken glass observed on returned vial per QV;
tired and needed to sleep; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (tired and needed to sleep) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045A21A and 030B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (tired and needed to sleep). At the time of the report, FATIGUE (tired and needed to sleep) outcome was unknown.            Patient had 1st dose on 01 May 2021. Concomitant medications were not reported. Treatment medications were not reported   This case was linked to MOD-2022-437577 (Patient Link).   Reporter did not allow further contact
LITTLE TIRED; PAIN WITH THE INJECTION; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 206A21A expiry: UNKNOWN) dose was not reported, administered on 02-JUL-2021 for prophylactic vaccination. No concomitant medications were reported.  On JUL-2021, the patient experienced little tired, and pain with the injection. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the little tired and pain with the injection was not reported. This report was non-serious.
After vaccination, within a week, patient was unresponsive to voice and facial stimulation from caregivers. She stared at lights or ceiling and would slowly look at a face after much coaxing. This continued for 3 to 4 months & was reported to the new pediatrician at 6 months of age. She was slow in all physical respects in learning to sit, crawl, walk and is still struggling with verbal skills at almost 5 years old. She is in physical therapy for toe walking and gait and stability as well. She had many issues that began after her 2 month vaccines and have continued since.
Nausea; Dizziness; This is a spontaneous report from a contactable consumer (patient). An 83 -year-old male patient receieved bnt162b2 (BNT162B2) , intramuscular on 2Jan2021 09:30 toat SINGLE DOSE for an COVID-19 immunizattion.  Medical history included lung disorder from an unknown date and unknown if ongoing had some lung issues in the past. She said that he was hospitalized in Jan2020 for something really odd , cough, pulmonary oedema  , atypical pneumonia, mycobacterial infection; Couple of years ago and had to take some IV medications through a PICC line and that was about 2 years ago and it has cleared up.  There were no concomitant medications.  The patient experienced nausea and  dizziness on 13Jan2021 04:00 The outcome of events was recovered.
FIRST VACCINE:  JANUARY 13, 2021:  ABOUT 7-9 DAYS AFTER FIRST SHOT, I HAD WHAT LOOKED LIKE DARK RED/PURPLE BUG BITES ON MY LOWER LEFT LEG.  IT STARTED OUT WITH ABOUT SIX AND EVERYDAY AFTER, I GOT MORE OF THE "BITE" LOOK.   IT THEN BECAME A LACY LOOK RASH THAT WAS DARK RED AND COVERED HALF OF MY LOWER LEG,  FROM MY SHIN TO MY CALF.  IT WAS ABOUT AN INCH OR SO UP FROM MY ANKLE AND A COUPLE INCHES FROM MY KNEE.  THIS RASH DID NOT EVER ITCH OR BURN AT ALL.  ITHE RASH WAS  GETTING WORSE SO I WENT TO A DERMATOLOGIST.   SUBSEQUENTLY, I HAD A FEW PALE ITCHY CIRCLES, SMALLER THAN A DIME ON MY ARM AND ABOUT SIX ON MY BACK.  THESE SLIGHTLY ITCHED.  THESE CAME OUT ABOUT WAS ABOUT TWO WEEKS AFTER MY LEG RASH APPEARED.  OTHER THAN THIS,  I HAD A SLIGHT SORE ARM SECOND VACCINE:  FEBRUARY 13, 2021 HAD VERY SORE ARM, STARTING A FEW HOURS LATER AFTER THE SHOT.   THE NEXT DAY, ARM WAS REALLY SORE AND I GOT A BAD HEADACHE THAT LASTED THE WHOLE DAY. AND DID NOT FEEL GOOD.  NEXT DAY, I WAS TOTALLY FINE.  THIRD NIGHT, I DEVELOPED A WELTY RASH ON MY RIGHT UPPER THIGH- ABOUT SIX SPOTS (JSUT SLIGHTLY SMALLER THAN A QUARTER)  THAT TURNED INTO RASH THE NEXT DAY.  I HAD A COUPLE WELTS ON MY UPPER LEFT THIGH, AS WELL AND SOME SMALLER WELTS, FOUR INCHES TO THE RIGHT OF MY BELLY BUTTON.  ABOUT ONE HOUR AFTER THESE SPOTS CAME OUT, I GOT VERY DIZZY.  I HAD THE DIZZY OFF AND ON FOR FIVE DAYS.  THE RASH SLIGHTLY ITCHED, BUT NOT BAD.  THESE RASHES BEGAN TO DISSIPATE A FEW DAYS AFTER INITIAL APPEARANCE.     I HAD ANOTHER RASH THAT APPEARED, 19 DAYS AFTER MY SECOND SHOT, WHICH I STILL HAVE.  RED, VERY ITCHY WELTS ON MY COVID ARM. INJECTION - UNDER ARM AND B Y THE INJECTIONS SITE- LARGE BULLS-EYE RASH AND SMALLER HARD BUMPS ON MY ARM AND NOW A FEW ON MY NECK AND AGAIN, ON MY OTHER ARM.  THE ITCHY WELTS CONTINUE TO APPEAR.
Patient received vaccine on 10/4/20. On 10/5/20, patient reports a fever of 101.5, chills, and body aches. Symptoms lasted for two days, then fever broke on 10/9/20. When fever broke, she broke out in mild shingles rash on her back and neck. This prompted her to seek medical attention at Urgent Care on 10/9/20. She was prescribed Valacyclovir there from Dr. She is still currently taking the medication as of 10/15/20.
whole body ached; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of general body pain in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced general body pain (Verbatim: whole body ached). The outcome of the general body pain was not reported.   It was unknown if the reporter considered the general body pain to be related to Shingles vaccine.     It was unknown if the company considered the general body pain to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 23-JUL-2023 The case was received by the patient via interactive digital media. This case was linked with case US2023AMR101663 same reporter but different patient.; Sender's Comments:  US-GSK-US2023AMR101663:Same reporter but different patient. Wife case
Fever of 101° , headache, chills, body and joint aches and pains, and upset stomach
Itching around the injection site; Redness below injection site/ it got really red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching around the injection site) and VACCINATION SITE ERYTHEMA (Redness below injection site/ it got really red) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031H20A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness below injection site/ it got really red). On 05-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Itching around the injection site). On 08-Mar-2021, VACCINATION SITE PRURITUS (Itching around the injection site) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (Redness below injection site/ it got really red) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. Treatment medications were unknown.
Patient developed fever and  9/10 RLQ pain 4 days post vaccine. He was admitted inpatient at Hospital for appendicitis that required appendectomy.
red Circle  on arm either at the injection site or right below it. circle is  about 3 inches in diameter.  It's been fading and getting lighter each day. There's not much left to it
2 days after the vaccine was given, pt experienced redness around the injection site which got larger in size and spread down her arm. Patient took benadryl as instructed by her doctor, and the redness did not go down. She has received an antibiotic for cephalexin and will be starting it today on 5/18/18. It has now been a week and I was informed of the event as of today.
Covid19 breakthrough.  1st Vaccine received on 01/08/2022.  90 y/o female with PMHx of DM, HTN, HLD presents to ED with c/o progressive weakness and cough x1 week.  Pt afebrile, room air sat 93% and CXR bilat diffuse patchy lung infiltrates concerning for PNA.  Pt treated with IV ABX.
A week after  first dose, started experiencing about 100(+) per day eye flashes in my left eye; odd visual images; This is a spontaneous report from a contactable healthcare professional. A 25-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the left arm on 26Feb2021(at the age of 25-year-old) as a single dose for COVID-19immunisation and also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 19Mar2021(at the age of 25-year-old) as a single dose for COVID-19immunisation. Medical history included asthma and small fiber neuropathy. Concomitant medications included ascorbic acid (VITAMIN C) for unknown indication on an unknown date and vitamin d nos (VITAMIN D)  for unknown indication on an unknown date, multivitamins (MANUFACTURER UNKNOWN) for unknown indication on an unknown date. The patient previously took metronidazole (MANUFACTURER UNKNOWN) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Mar2021 the patient experienced eye flashes, it was reported that about 100(+) per day eye flashes in left eye, gone to both an ophthalmologist, who stated eyes were fine, and a neurologist who ran brain tests and did not find anything. The neurologist also theorized that this could be related to the vaccine. The event resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the event. . On an unknown date, the patient underwent COVID-19 virus test and the result was negative. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the event eye flashes  left eye was unknown.   No follow-up attempts are needed. No further information is expected.
This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), RASH PRURITIC (a rash on the arm which was itchy) and HEADACHE (more headaches than usual) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. No Medical History information was reported. On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), RASH PRURITIC (a rash on the arm which was itchy) and HEADACHE (more headaches than usual). At the time of the report, PAIN IN EXTREMITY (Sore arm), RASH PRURITIC (a rash on the arm which was itchy) and HEADACHE (more headaches than usual) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were not reported. Treatment information was not reported.
I'm curious about this condition called Myocarditis, and I think I'm experiencing symptoms of this conditions'; This is a spontaneous report from a contactable consumer (patient). A 71-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 06Apr2021 (Batch/Lot Number: EN6208) as 2nd dose, single for covid-19 immunisation. No patient history. No other medical conditions. Concomitant medications included periodically thyroid medication. The patient received first dose of BNT162B2 on 11Mar2021 (lot number: EN6202) at age of 71 years old for covid-19 immunisation. Patient was curious about this condition called myocarditis and he think he was experiencing symptoms of this conditions, this kind brought on his Pfizer vaccine and so Pfizer was his first contact right now and there was couple of numbers on the sheet when he got his second vaccine shot. The outcome of event was unknown.
Administered dosage listed on the vial of 0.5 ml. This was a booster dose that was supposed to be 0.25ml. No adverse reaction or treatment required.